- TRULICITY (dulagluTIDE)
(Available = 0.75mg or 1.5mg per 0.5ml) - How to use from the manufacturer
- Dose
- 0.75mg SQ once weekly; may ↑ to 1.5mg
- Missed dose if < 3 days from next dose, wait until the next dose
- Mechanism of Action
- TRULICITY contains dulaglutide, which is a human GLP-1 receptor agonist with 90% amino acid sequence homology to endogenous human GLP-1 (7-37). Dulaglutide activates the GLP-1 receptor, a membrane-bound cell-surface receptor coupled to adenylyl cyclase in pancreatic beta cells. Dulaglutide increases intracellular cyclic AMP (cAMP) in beta cells leading to glucose-dependent insulin release. Dulaglutide also decreases glucagon secretion and slows gastric emptying.
- TRULICITY lowers fasting glucose and reduces postprandial glucose (PPG) concentrations in patients with type 2 diabetes mellitus. The reduction in fasting and postprandial glucose can be observed after a single dose.
- Storage
- Refrigerator or RT x 14 days
- BYDUREON (exenaTIDE) (Available = 2mg)
- How to use Bydureon
- Dose
- 2mg SQ once weekly
- TANZEUM (albigluTIDE)
Monday, February 13, 2017
List of GLP-1 Receptor Agonist
NOTE: so patient asked how to use TRULICITY (dulaglutide), and I remember it's a weekly dose, but how to use...not a clue :( Here is the answer :) By the way, they all belong to Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment